StockClub

PTGX

PTGXProtagonist Therapeutics, Inc.$ --
Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc.

PTGX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
56M USD
YoY +99.0%
Operating Income
-4M USD
YoY +81.1%
Net Income
4M USD
YoY +132.5%
EPS
0.06$
YoY +130.6%

Revenue

$56.4M
FY2024 Q2$259.1M
$259.1M
Q2
FY2024 Q3$263.8M
$263.8M
Q3
FY2024 Q4$434.4M
$434.4M
Q4
FY2025 Q1$28.3M
$28.3M
Q1
FY2025 Q2$33.9M
$33.9M
Q2
FY2025 Q3$38.6M
$38.6M
Q3
FY2025 Q4$46M
$46M
Q4
FY2026 Q1$56.4M
$56.4M
Q1
Actual
+$28M (+99.0%)

Net Income

$3.8M
FY2024 Q2$176.7M
$176.7M
Q2
FY2024 Q3$143.5M
$143.5M
Q3
FY2024 Q4$275.2M
$275.2M
Q4
FY2025 Q1$-11.7M
$-11.7M
Q1
FY2025 Q2$-46.4M
$-46.4M
Q2
FY2025 Q3$-85.8M
$-85.8M
Q3
FY2025 Q4$-130.1M
$-130.1M
Q4
FY2026 Q1$3.8M
$3.8M
Q1
Actual
+$15.4M (+132.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$28.6M
Est:$25.7M
FY2020BEAT
$28.6M
FY2021BEAT
Actual:$27.4M
Est:$23.2M
FY2021BEAT
$27.4M
FY2022MISS
Actual:$26.6M
Est:$29.9M
FY2022MISS
$26.6M
FY2023MISS
Actual:$60M
Est:$315M
FY2023MISS
$60M
FY2024BEAT
Actual:$434.4M
Est:$382M
FY2024BEAT
$434.4M
FY2025MISS
Actual:$46M
Est:$47M
FY2025MISS
$46M

Analyst Estimates